Sorrento Therape (SRNE) earnings · rev $62.8M
These earnings events as JSON? API free 100/daySorrento Therape (SRNE) is a biotechnology company listed on OTCQB.
This SRNE earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SRNE revenue for 2022-12-31 was $62.8M. Net income was -$572.8M. Revenue was down 48.5% from 2017-09-30 to 2022-12-31. SRNE currently screens at market cap $385.9K.
When the next SRNE 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 48.5% from 2017-09-30 to 2022-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full SRNE research stays on the stock page; the tape stays on the quote page.
SRNE earnings FAQ
What are SRNE's latest revenue and net income?
Latest cached Sorrento Therape (SRNE) revenue for Dec 31, 2022 was $62.8M. Net income was -$572.8M. Statements: https://lician.com/financials/srne
What is SRNE's latest diluted EPS?
Latest cached Sorrento Therape (SRNE) diluted EPS for Dec 31, 2022 was -$1.37.
What period does the latest SRNE earnings print cover?
The latest cached Sorrento Therape (SRNE) earnings print covers Dec 31, 2022. The prior cached period on this page is Sep 30, 2017.
How did SRNE revenue change from the prior cached period?
Cached Sorrento Therape (SRNE) revenue was down 48.5% from $121.9M (Sep 30, 2017) to $62.8M (Dec 31, 2022). Statements: https://lician.com/financials/srne
Where are SRNE earnings listed?
Cached earnings facts for Sorrento Therape (SRNE) are listed at https://lician.com/earnings/srne. Statements: https://lician.com/financials/srne
Not investment advice.